Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

ifeminists April 5, 2006 Carey Roberts	Women's Health Hoax Today, the women's health movement in America has become a multi-billion dollar interest group that tap-dances smoothly among feckless bureaucrats and chivalrous congressmen looking to woo the female vote.
Reason May 2001 Cathy Young	False Diagnosis When it comes to gender, doctors don't play favorites...
Salon.com September 20, 2000 Cathy Young	Medical gender wars First came the whining feminists. Next, the inevitable male backlash. Health research has become a casualty of the battle between the sexes.
ifeminists October 15, 2002 Sacks & Thompson	When Men's Health Doesn't Count Congress is sending a message to American men: men's health doesn't count.
ifeminists May 27, 2003 Carey Roberts	Unfit to Print: Case Study in Deceit at the New York Times This is the account of a fact-finding study that was issued by a governmental agency, how the New York Times grossly misreported the study, and how the myth nurtured by the NYT story ultimately influenced the federal legislative process.
ifeminists March 31, 2004 Carey Roberts	Where Have All The Young Men Gone? This article gives reasons why more women may spend their golden years alone. These reasons range from men not wanting to marry, to there being more women than men, to women living longer.
ifeminists October 21, 2003 Carey Roberts	Why Hillary Won't Be Elected the First Female President Things are looking bleak for advocates who are pushing for a woman president in 2004.
ifeminists October 29, 2002 Rondi Adamson	Re-Evaluating the Risk of Breast Cancer As breast cancer became a poster disease for feminism in the 1980s, the attention it began to receive took on unreasonable proportions. In short, the intensity of funding, publicity and research around breast cancer is not based on need. It is based on politics.
Chemistry World June 8, 2015 Rebecca Trager	NIH drug manufacturing unit shut down The halt could potentially affect 46 clinical trials, and about 250 patients who are either receiving, or about to receive, products manufactured at the facility.
AskMen.com Richard Stevens	Participating In Clinical Trials Check out what participating in clinical trials involves and how you can join a study. You may even make some cash in the process.
The Motley Fool June 29, 2007 Brian Orelli	The Phase 2 Blues Drug developer Cytokinetics disappoints investors with failed clinical trials.
Information Today July 9, 2015	The BMJ Requires Patient-Level Data for Publication The BMJ is now applying its data-sharing policy to all clinical trials.
AskMen.com September 30, 2000 Joshua Levine	Male Breast Cancer Breast cancer is traditionally thought of as a female-related problem. Men, however, are as susceptible to the disease as women are. In many ways, the disease appears similarly in both sexes...
ifeminists February 9, 2005 Trudy W. Schuett	Superbowl Myth Has More Lives Than A Cat Before the 1993 Super Bowl game, a report cited higher domestic violence after Super Bowl games. The Washington Post quickly disproved the claim. Ten years later, the practical result is a law that discriminates against male victims, and refuses to acknowledge the existence of abusive women who need help.
Bio-IT World March 8, 2005 Mark D. Uehling	Is That a Target on Her Back? Q&A with Deborah Zarin, head of ClinicalTrials.gov, the matchmaking Web site for patients seeking to participate in federally sponsored clinical trials.
BusinessWeek February 19, 2007 Gene G. Marcial	Will Healthy Lab Data Revive Ailing Cell Genesys? Cell genesys is in the midst of clinical trials of vaccines for prostate and pancreatic cancer that analysts believe should catch investors' eyes.
The Motley Fool June 17, 2010 Luke Timmerman	Oncothyreon's Cancer Vaccine Back in the Saddle as Merck KGaA Re-Starts Clinical Trials The German-based Merck got clearance from the FDA and local ethics review boards to resume two of three large pivotal trials.
Geotimes November 2004	Open Access: Open Debate? Imagine any U.S. citizen having free and open access to research funded with tax dollars. That possibility could be closer to reality than ever before, but Congress must first address some important concerns
BusinessWeek May 23, 2005 Catherine Arnst	If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer.
ifeminists June 10, 2003 Wendy McElroy	The Anti-Male New York Times For years, the Times -- America's "newspaper of record" -- has been a vehicle for political correctness in both subtle and blatant ways. Examining its policies provides an interesting window into the anti-male and liberal bias rampant in most current media.
Chemistry World August 7, 2013 Emma Stoye	AllTrials releases plan for clinical trial reporting The organizations behind AllTrials, a public campaign calling for detailed information on clinical trials to be publically available, have put together a detailed plan on how to achieve clinical trial reporting on a global scale.
Bio-IT World January 21, 2005 John Otrompke	Recruiting in the Workplace With hundreds of new therapeutic agents in the pipeline, it is no wonder that clinical trials sponsors are looking to organize trials around the workplace.
Managed Care March 2007 Martin Sipkoff	Managing Cancer Treatment Begins Before Diagnosis Health plans are increasingly involved in promoting the lifestyle changes that help their members avoid cancer, and are increasingly involved in clinical trials if prevention fails.
Bio-IT World March 10, 2003 Dawn Stover	E-Recruitment: Trial by Wire Online databases are helping patients find clinical trials -- but e-recruitment is no panacea for participant shortages.
The Motley Fool April 28, 2009 Brian Orelli	Headline? Bad! Unexpected? No! For a company that only has one drug on the market, stopping a failing phase 3 clinical trial that's designed to expand the market of that drug is usually a major blow. But Onyx Pharmaceuticals was able to shrug it off.
Reason October 2007 Ronald Bailey	Is Industry-Funded Science Killing You? The overrated risks and underrated benefits of pharmaceutical research "conflicts of interest."
Chemistry World September 26, 2014 Rebecca Trager	NIH wants scientists to consider sex in research The US National Institutes of Health has invested an additional $10 million in studies that will consider sex and gender as a fundamental variable in research.
Information Today September 13, 2004 Barbara Quint	NIH Requires Open Access for Its Funded Medical Research With the NIH's decision, the fast-paced open access movement has picked up even more momentum.
Fast Company July 1, 2007	Going on the Gold Standard What it takes for your company to join the cancer fight.
Chemistry World November 12, 2013 Dinsa Sachan	Rough patch for India's clinical trial industry The Indian clinical trial industry is beset by uncertainty. Campaigners have petitioned the courts claiming that drug companies are exploiting poor people and this has led to more than 100 trials being put on hold.
Pharmaceutical Executive February 1, 2011 Jill Wechsler	The Building Block of Drug Discovery With Francis Collins now calling the shots at NIH, will be be able to deliver on the innovations behind the genome?
Fast Company December 2009 Erica Westly	The Price of Winning FDA Approval Approval for a new drug or medical treatment requires extensive -- and expensive -- human trials for safety and effectiveness.
Managed Care July 2005 Martin Sipkoff	Support Grows for Establishing National Clinical Trial Registry Stakeholders are pushing for a national clinical trial registry, and efforts by UnitedHealth Group are in the forefront. Medical journals are setting hard and fast rules.
American Journal of Nursing October 2010 Eileen Thomas	Men's Awareness and Knowledge of Male Breast Cancer This article reports on the findings of a qualitative study that explored the awareness and knowledge of male breast cancer among English-speaking men.
The Motley Fool April 19, 2004 Charly Travers	4 Promising Biotech IPOs Several recently gone-public biotechs boast surprisingly interesting drug pipelines. From drugs for hepatitis to hopeful cancer treatments, watch out for these four biotech debutantes. If trials go smoothly, they may be the next up-and-coming stocks in the industry.
American Family Physician December 15, 2002 Randhawa & Fink	Screening for Breast Cancer A case study and question-and-answer group on screening for breast cancer, based on the recommendations of the current U.S. Preventive Services Task Force
AskMen.com Sabrina Rogers	Can Men Get Breat Cancer? Breast cancer isn't just a chick thing. Although it is about 100 times more common among women and is a rare cause of death in men, the American Cancer Society estimates that, in 2004, approximately 1,450 American men will be diagnosed with this disease.
Chemistry World January 25, 2013 Rajesh Parishwad	Indian supreme court's anger over unregulated clinical trials The fledgling clinical trials industry in India has been hit by recent revelations of a lack of regulation. Now, the country's supreme court has criticized the body that oversees clinical trials for its inaction in the face of these unethical practices.
Reason June 2005 Kerry Howley	Scientists for Sale Innovation vs. ethics: Scientists at the NIH have discovered many things over the years, but evidently they haven't yet found a way to balance innovation and objectivity.
Salon.com November 10, 2000 Laurie Tarkan	The business of breast cancer Big medicine is making big bucks on the disease, but we're still far from a cure...
Chemistry World June 25, 2015 Rebecca Trager	NIH plan to get drug development unit back online The NIH has set out key milestones in its plan, including training and re-training personnel in good manufacturing practice regulations by August.
Information Today June 16, 2015	NIH Plans for the Future of the National Library of Medicine The National Institutes of Health's director, Francis S. Collins, approved the proposed strategic plan for the National Library of Medicine.
Information Today October 2004 Barbara Quint	Up Front with Barbara Quint: Future of the NIH Open Access Policy Basically, the NIH, funder of at least a quarter of the world's best medical research, will mandate that all grantees and contractors submit electronic copies of finished manuscripts for full-text release through PubMed Central, the National Library of Medicine's popular medical research site.
Chemistry World July 31, 2013 Daniel Johnson	Animal testing failures put drug trial volunteers in danger The reporting of animal studies is biased, inflating the efficacy of drug candidates and pushing them into the clinic before they are ready.
Salon.com October 12, 1999 Damien Cave	Male mastectomy Not many men get breast cancer, but too few are aware of the risk.
The Motley Fool May 4, 2009 Robert Steyer	Beyond Provenge -- The Next Hot Cancer Drug? The search for prostate cancer treatments is filled with prospects and littered with failures. Which companies have the best chance of success?
Bio-IT World January 21, 2005 Sprouse & Shiple	Strategic Insights: Building Integrated Research Networks Uniting a region's medical centers on clinical projects could create a new model for clinical trials.
BusinessWeek August 15, 2005	Misonix Zaps Prostate Cancer Misonix, a maker of medical and scientific gear, has investors interested in its new ultrasound device for prostate cancer. Shares have risen from $5.22 on Apr. 18 to $6.50 on Aug. 3.